RPE65-associated retinal dystrophy (RPE65-RD) is thought to account for approximately 5% to 16% of LCA, and successful gene replacement has been demonstrated in phase I/II and III clinical trials.2 Here, RPE65 is linked to Leber congenital amaurosis.